Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 420-424

  Feitosa, Mary F ^a   Reiner, Alexander P ^b   Wojczynski, Mary K ^a   Graff, Mariaelisa ^c   North, Kari E ^d   Carr, Jeffrey J ^e   Borecki, Ingrid B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Glucose metabolism; Insulin resistance; Nonalcoholic steatohepatitis; Sex specific association

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; INSULIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CARDIOMETABOLIC RISK; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ALANINE TRANSAMINASE; ANGIOPLASTY; CORONARY DISEASE; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS;

EID: 84875056135     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.013     Document Type: Article

References (28)

1. Lewis J.R., Mohanty S.R. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010, 55:560-578.
2. Mulhall B.P., Ong J.P., Younossi Z.M. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002, 17:1136-1143.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
4. Byrne C.D., Olufadi R., Bruce K.D., Cagampang F.R., Ahmed M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 2009, 116:539-564.
5. Kodama Y., Ng C.S., Wu T.T., et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007, 188:1307-1312.
6. Boyce C.J., Pickhardt P.J., Kim D.H., et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010, 194:623-628.
7. Yamada J., Tomiyama H., Yambe M., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006, 189:198-205.
8. Schindhelm R.K., Diamant M., Dekker J.M., Tushuizen M.E., Teerlink T., Heine R.J. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006, 22:437-443.
9. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
10. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143:722-728.
11. Marchesini G., Bugianesi E., Forlani G., et al. Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
12. Treeprasertsuk S., Lopez-Jimenez F., Lindor K.D. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci 2011, 56:35-45.
13. Hamaguchi M., Kojima T., Takeda N., et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007, 13:1579-1584.
14. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
15. Fraser A., Harris R., Sattar N., Ebrahim S., Smith G.D., Lawlor D.A. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007, 27:2729-2735.
16. Nseir W., Shalata A., Marmor A., Assy N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci 2011, 56:3439-3449.
17. Higgins M., Province M., Heiss G., Eckfeldt J., et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996, 143:1219-1228.
18. Giannini E.G., Testa R., Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005, 172:367-379.
19. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972, 18:499.
20. Jung D.H., Lee Y.J., Ahn H.Y., Shim J.Y., Lee H.R. Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification. Clin Chem Lab Med 2010, 48:1829-1834.
21. Wang C.C., Lin S.K., Tseng Y.F., et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009, 24:1411-1416.
22. Haring R., Wallaschofski H., Nauck M., Dörr M., Baumeister S.E., Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009, 50:1403-1411.
23. McKimmie R.L., Daniel K.R., Carr J.J., et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008, 103:3029-3035.
24. Malaguarnera M., Di Rosa M., Nicoletti F., Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl) 2009, 87:679-695.
25. Targher G., Bertolini L., Padovani R., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007, 30:1212-1218.
26. Ioannou G.N., Weiss N.S., Boyko E.J., Mozaffarian D., Lee S.P. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 2006, 43:1145-1151.
27. Hung A.M., Sundell M.B., Egbert P., et al. A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol 2011, 6:767-774.
28. Lawton J.S. Sex and gender differences in coronary artery disease. Semin Thorac Cardiovasc Surg 2011, 23:126-130.